Create a Free Account
or
Create a Free Account
or
| # | Filing Date | Period End Date | Type | Report Link |
|---|---|---|---|---|
| No Data found | ||||
| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
Whitehawk Therapeutics (NASDAQ:WHWK) reported quarterly losses of $(0.26) per share which missed the analyst consensus estimate...
Whitehawk Therapeutics, Inc. (NASDAQ:WHWK), an oncology therapeutics company applying advanced technologies to established tumo...
Top large-cap losers last week included IonQ, Tempus AI, AeroVironment, Astera Labs, Nebius, Kratos, F5, Klarna, Leonardo DRS, ...
Whitehawk Therapeutics announced a multi-year partnership with Tempus AI, but its stock fell 8.81% in after-hours trading follo...
Whitehawk Therapeutics shares are rising Thursday after the company announced a multi-year collaboration with Tempus AI to supp...
Tempus AI, Inc. (NASDAQ:TEM), a technology company leading the adoption of AI to advance precision medicine, today announced a ...
Whitehawk Therapeutics (NASDAQ:WHWK) reported quarterly losses of $(0.76) per share which missed the analyst consensus estimate...
Whitehawk Therapeutics (NASDAQ:WHWK) reported quarterly earnings of $1.83 per share which beat the analyst consensus estimate o...
